1) DST
[英][,di: es 'ti:] [美]['di 'ɛs 'ti]
供者特异性脾细胞输注
1.
Change of Activity of NF-κB p65 in Mice with Peripheral Tolerance Induced by DST;
供者特异性脾细胞输注诱导外周耐受小鼠不同组织细胞内NF-κB p65的活性变化
3) Donor lymphocyte infusion
供者淋巴细胞输注
1.
To explore whether the complete donor chimerism could be achieved and graft-versus-host disease could be alleviated by donor lymphocyte infusion which was sensitized by the skin of the recipient, female C57BL/6 mice (H-2~b, B6) as recipients received total body irradiation (TBI) of 5.
本研究目的是探讨经受者皮肤致敏后的异基因供者淋巴细胞输注(DLI)是否能在促进形成完全供者嵌合(CC)的同时减轻移植物抗宿主病(GVHD)。
2.
Objective To explore the effect of donor lymphocyte infusion on H22 hepatoma mice.
目的:观察供者淋巴细胞输注(DLI)对小鼠H2 2肝癌的治疗作用。
3.
ObjectiveTo evaluate the efficacy and complications of donor lymphocyte infusion (DLI) following nonmyeloablative stem cell transplantation(NSCT)for the patients with hematologic diseases.
【目的】研究非清髓性造血干细胞移植治疗血液病和供者淋巴细胞输注的疗效及并发症。
4) DLI
供者淋巴细胞输注
1.
2 weeks after NST, the donor lymphocytic infusion (DLI) was given , and at totals 5 to 6 times for each patient.
方法 :采用氟达拉宾、白消安、抗人淋巴细胞球蛋白和骁悉的非清髓性预处理 ,异基因造血干细胞移植 ,移植后 2周开始供者淋巴细胞输注 (DLI) ,每例 5～ 6次 ;应用STR PCR及染色体核型分析检测供者嵌合体 ;每半月～ 1个月监测血型。
5) donor lymphocytes infusion
供者淋巴细胞输注
1.
Objective To investigate the clonal expansion of T cell receptor (TCR) V? subfamily T cells which were considered as GVL effective cells alter donor lymphocytes infusion ( DLI) in patients with relapse chronic myelogenous leukemia (CML) after allogeneic hone marrow transplantation (allo-BMT).
目的 了解供者淋巴细胞输注(DLI)治疗异基因骨髓移植(allo-BMT)后慢性粒细胞白血病(CML)复发患者,产生GVL效应的克隆性TCRVβ亚家族T细胞的情况。
6) donor stem cell infusion
供者造血干细胞输注
1.
To evaluate the effects of donor stem cell infusion (DSI) in patients after nonmyeloablative allogeneic peripheral blood stem cell transplantation( NAPBSCT),6 patients were infused donor stem cell in+7d～+90d consisting of MNC (0.
为探讨供者造血干细胞输注 (DSI)在非清髓异基因外周血干细胞移植 (NAPBSCT)中的作用 ,6例NAPBSCT患者分别在移植后 +7～ +90天进行DSI治疗 ,共输注单个核细胞 (MNC) (0 。
补充资料：肝细胞特异性脂蛋白抗体
肝细胞特异性脂蛋白抗体
liver cell specific lipoprotein antibody,LSP
肝细胞特异性脂蛋白(LSP)的特异性抗体。用LSP单克隆抗体B2作ELISA检测，只与肝起反应，与肾、胃、甲状腺、胰腺等不起反应。慢性活动性肝炎血清中抗LSP检出率很高，且与疾病活动程度密切相关；急性病毒性肝炎阳性率也较高，但恢复期即转阴。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条